Who Paid My Doc
Carrie Hall
Nurse Practitioner, Obstetrics & Gynecology Gaffney, SC Nurse Practitioner
NPI 1659756310 CMS profile 11039460
1506 N Limestone St Ste C, Gaffney, SC 29340
General payments
$794
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Carrie Hall of Gaffney, SC is reported in the CMS Open Payments database as having received $794 across 40 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 70th percentile of Nurse Practitioner, Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $360 | 17 | |
| 2024 | General | $246 | 12 | |
| 2023 | General | $161 | 10 | |
| 2022 | General | $28 | 1 |
Beside peers
- Carrie Hall
- Nurse Practitioner, Obstetrics & Gynecology median
- Middle half of Nurse Practitioner, Obstetrics & Gynecology
- National median
In program year 2025, general payments to Carrie Hall were reported at $360. Among 1,030 Nurse Practitioner, Obstetrics & Gynecology profiles paid that year, the median was $151 and the middle half received between $51 and $371.
Show as a table
| Year | Carrie Hall | Nurse Practitioner, Obstetrics & Gynecology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $135 | $40–$338 | $132 |
| 2022 | $28 | $143 | $45–$386 | $149 |
| 2023 | $161 | $153 | $54–$411 | $160 |
| 2024 | $246 | $140 | $45–$326 | $164 |
| 2025 | $360 | $151 | $51–$371 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 8 drugsPart D claims
148
Drug cost
$2,868
Branded share of claims
9.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Norethindrone | Generic | 25 | $547 | |
| Valacyclovir Valacyclovir Hcl | Brand | 14 | $489 | |
| Norethindrone Acetate | Generic | 11 | $462 | |
| Estradiol | Generic | 29 | $454 | |
| Metronidazole | Generic | 12 | $426 | |
| Medroxyprogesterone Acetate | Generic | 21 | $234 | |
| Fluconazole | Generic | 13 | $172 | |
| Triamcinolone Acetonide | Generic | 23 | $84 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Payments and prescribing
First 5 of 7 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| Veozah |
|
$71 | — | — |
| INJECTAFER |
|
$23 | — | — |
| Bimzelx |
|
$21 | — | — |
| ABRYSVO |
|
$12 | — | — |
| DUAVEE |
|
$10 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
See all 7 in the dashboard with a free accountRecords
40 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Obstetrics & Gynecology in South Carolina
Jean Isherwood
Nurse Practitioner, Obstetrics & Gynecology · Lexington, SC
Michelle Toole
Nurse Practitioner, Obstetrics & Gynecology · West Columbia, SC
Misty Sawyer
Nurse Practitioner, Obstetrics & Gynecology · Irmo, SC
Charlene Bunger
Nurse Practitioner, Obstetrics & Gynecology · Conway, SC
Sheena Vaccaro
Nurse Practitioner, Obstetrics & Gynecology · West Columbia, SC
Cynthia Koli
Nurse Practitioner, Obstetrics & Gynecology · West Columbia, SC
Related records
Nurse Practitioner, Obstetrics & Gynecology in South Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Obstetrics & Gynecology
Everyone recorded under this specialty, nationwide.
Doctors in South Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.